Folic acid-appended galactoxyloglucan-capped iron oxide nanoparticles as a biocompatible nanotheranostic agent for tumor-targeted delivery of doxorubicin
B. S. Unnikrishnan, Anitha Sen, G.U. Preethi, Manu M. Joseph, S. Maya, R. Shiji, K. S. Anusree, T.T. Sreelekha
Topics & Concepts
DoxorubicinPharmacologyFolate receptorCytotoxicityDrug deliveryChemistryToxicityIron oxide nanoparticlesBiodistributionTransferrin receptorTargeted drug deliveryIn vivoDrugCancer researchIron oxideTransferrinMedicineIn vitroChemotherapyBiochemistryCancer cellCancerSurgeryInternal medicineBiologyOrganic chemistryBiotechnologyNanoparticle-Based Drug DeliveryGraphene and Nanomaterials ApplicationsNanoplatforms for cancer theranostics